Emulate

Emulate is a pioneer in the Organ-on-a-Chip field, providing human-relevant in vitro models for pharmaceutical research and development. Its technology platform, which includes specialized chips like the Brain-Chip, is designed to model complex human organ systems such as the neurovascular unit to study drug transport, toxicity, and disease mechanisms. The company has gained significant regulatory traction, including acceptance into the FDA's ISTAND program, and collaborates with major industry partners. Emulate is positioned at the forefront of a regulatory shift towards New Approach Methodologies (NAMs) in preclinical testing.

Organ-on-a-Chip microfluidic systems that emulate human organ biology, incorporating living human cells, physiological flow, and mechanical forces. Includes integrated hardware (Zoë Culture Module, Hera Feeding System) and AI-driven software for scalable experimentation and analysis.

Emulate competes in the microphysiological systems (MPS) or Organ-on-a-Chip market against other companies like Mimetas, TissUse, and CN Bio, as well as academic consortia. Its key competitive advantages include its first-mover status, extensive publication record, unique FDA ISTAND program acceptance, and integrated hardware/software platform.